Minister of Food and Drug Safety: “Mifjin needs to be legalized to relieve damage from side effects”

Decided not to proceed with clinical trials for Koreans... “There are no unusual cases by race.”

(Seoul = Yonhap News) Reporter Shin Seon-mi = The Ministry of Food and Drug Safety reiterated the need for a legal mechanism to ensure the safe use of 'Mifgin', widely known as a pregnancy abortion drug, and to provide relief from damage.

Minister of Food and Drug Safety Oh Yoo-kyung responded to a question about the side effects of Mifjin at the National Assembly Health and Welfare Committee audit held on the 13th, saying, "Currently, young women in our country illegally receive drugs with severe side effects, which is a 'blind spot' in which they are not protected. Considering safety concerns, I think it is right to approach this in a more legal way that can also provide relief to these women."

Last month, the government announced its policy to introduce abortion drugs, and the Ministry of Food and Drug Safety decided to pursue related procedures with the goal of introduction within the first quarter of next year.

The Ministry of Food and Drug Safety indicated at the general meeting of the Health and Welfare Committee last month that there were no plans for a bridge test for Koreans regarding the introduction of Mifjin, and also announced that there was no change in its position during the National Assembly audit on the same day.

A bridging test is a test that looks at differences in the safety and effectiveness of a drug by race or country.

Regarding the test plan, Director Oh said, “As far as I know, no special adverse reactions have been confirmed with MIFGENE by race or country.”